News and Client Developments:

Keith Gregg joins Entrepreneur Center as health care expert
Nashville Business Journal by Chris Silva, Staff Reporter
Date: Friday, November 11, 2011, 2:40pm CST

The Entrepreneur Center today named Keith Gregg as its entrepreneur-in-residence for health care.

Gregg, chairman of JRG Ventures, has over 25 years of experience in life sciences, health care IT and disruptive information systems environments.

“With the growth of Nashville’s health care and tech-enabled… service sectors, Keith brings an incredible level of operational experience and perspective to the table,” said Michael Burcham, president and CEO of the Entrepreneur Center, in a news release. “By having his experience in-house, we can help more and better health care tech companies launch in Nashville.”

Gregg is also a certified licensing professional and specializes in assisting entrepreneurs, investors and executives implement growth strategies to accelerate value. Read Full Article

CosmosID™
CosmosID™ delivers a revolutionary solution for pathogen diagnosis that is faster, more accurate and cost-effective than the current standards for identifying infectious diseases and microbial agents.

Our proprietary computational approach to genomic identification is a significant breakthrough in its ability to quickly and accurately identify contaminants of the food and water supplies and health risks posed by dangerous microorganisms including enhanced and engineered threats.

Health Care REIT, Inc.
"Health Care REIT, Inc. is a publicly traded real estate investment trust with an enterprise value of more than $12 billion. Health Care REIT's portfolio spans the full spectrum of health care real estate, including senior living communities, medical office buildings, inpatient and outpatient medical centers and life science facilities.

JRG Ventures and Health Care REIT are partnering on the creation of research, technology and healthcare integrated platforms throughout the United States."..  More 

Errant Gene Therapeutics
Errant Gene Therapeutics, LLC™ (EGT) is a privately held biopharmaceutical company established in 2003. The company's mission is the development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as “orphan diseases.” EGT is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many of these diseases. EGT therapies are currently being developed for hemoglobinopathies and selected cancers..  More 

IMI Health completes purchase of Boundary Medical
The combination of IMI and Boundary creates a new and unique outcomes data capture mechanism for healthcare and pharmaceutical, biotechnology, device, diagnostic companies and leverages IMI Health's novel analytical tools to convert data into information.
This information can then be used to show comparative effectiveness of treatment/drug protocols and move therapeutic pathways toward better personalized medicine.  More 

Diatherix Laboratories
Releases first clinically available test for confirmation of H1N1.  More 

Keith Gregg appointed Chairman, Masters of Science in Professional Science Finance Committee
Middle Tennessee State University (MTSU). More 

Public Health Television launches in Tennessee
Providing healthcare educational outreach to rural
and community healthcare centers. More 

arGentis Pharmaceuticals
arGentis Pharmaceuticals retains JRG Ventures to license their mid- and late-stage platform technologies in both autoimmunity and ophthalmology...    More 

The FOLDRite™ System
JRG Ventures assisted Network PDF in reformulating the company,
identifying partners, and positioning FOLDRite for licensing... More 

PointStake™
JRG provides corporate strategy, management, and structural support to launch the company and gain clients... More 

Public Health Television™
JRG engaged to find strategic partners and sales avenues ... More 

Med BioGene™
JRG engaged to build the company portfolio and secure licensing
opportunities ... More 

Vertichem
Vertichem is a fully integrated renewable energy company focused on developing a portfolio of biofuels, energy and bioproducts that contribute to the sustainability of our environment. ... More